Stoke Therapeutics, Inc. (STOK)
33.00
+2.13
(+6.90%)
USD |
NASDAQ |
Dec 08, 16:00
33.03
+0.03
(+0.09%)
After-Hours: 20:00
Stoke Therapeutics Shareholders Equity (Quarterly): 308.10M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.21B |
| Janux Therapeutics, Inc. | 976.56M |
| Insmed, Inc. | 945.57M |
| Sarepta Therapeutics, Inc. | 1.320B |
| Aldeyra Therapeutics, Inc. | 49.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 360.26M |
| Total Liabilities (Quarterly) | 52.16M |
| Debt to Equity Ratio | 0.0155 |
| Current Ratio | 6.529 |
| Net Debt Paydown Yield | 0.02% |